Twist Bioscience Corporation Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Twist Bioscience CorporationHeadquarters: South San Francisco, 
                        CA, United States
                    
Employees: 652
CEO: Dr. Emily Marine Leproust Ph.D.

                                    NASDAQ: TWST
                                
                                            -8.36%
                                            
Market Cap$3.18 Billion

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

Twist Bioscience Corporation Categories

United States Healthcare Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Twist Bioscience Corporation market capitalization over time

Evolution of Twist Bioscience Corporation market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Twist Bioscience Corporation

Top Competitors by Market Capitalization

Industry: Diagnostics & Research

Company	Market Cap (USD)
Thermo Fisher Scientific	$219.88 B
Danaher	$177.43 B
Siemens Healthineers AG	$59.19 B
Agilent Technologies, Inc.	$43.57 B
Lonza Group Ltd	$41.66 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Sept. 30, 2024
Revenue TTM	$295.2 M
EBITDA	$-156,666,000
Gross Profit TTM	$119.6 M
Profit Margin	-74.63%
Operating Margin	-54.00%
Quarterly Revenue Growth	27.80%